Oncolytics Biotech Inc (ONC) — Capital Reinvestment Ratio

Latest as of June 2018: 0.06x

Oncolytics Biotech Inc (ONC) has a Capital Reinvestment Ratio of 0.06x as of June 2018, meaning it reinvests 0% of its operating cash flow (CA$589.26K) in capital expenditures (CA$37.44K). See ONC net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

CA$589.26K

CAD

Capital Expenditures

CA$37.44K

CAD

Data as of

Jun 2018

Most recent filing

Annual Capital Reinvestment Ratio for Oncolytics Biotech Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Oncolytics Biotech Inc from None to None. For live market cap and broader valuation context, see Oncolytics Biotech Inc (ONC) market capitalisation.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow